Introduction
The antitumor activity of Thio-TEPA (Triethyleneiminethiophosphoramide, TT) has been known since 1953 [1, 2] . In the past, the drug has been used clinically against ovarian carcinoma, Hodgkin's disease, carcinoma of the breast and other malignancies [3] . In recent years, however, it has not enjoyed wide-spread clinical application because of its toxicity. Although many synthetic modifications of Thio-TEPA have been made over the years, no substantial improvement in lowering the toxicity and raising the activity levels has been achieved.
In the last decade, an approach basically different from the past attempts has been made [ whereby one aziridinyl moiety of Thio-TEPA has been replaced by a moiety which not only may change the biological characteristics of the drug, but also may serve as a marker, such as a nitroxyl spin label, for monitoring the metabolic pathway of the drug.
Emanuel and coworkers reported [6] that the Thio-TEPA analog containing the NH-bridged spin label (SL-NH-TT) has a lower toxicity and a higher antitumor activity than thio-TEPA. Since some of these data [6] were difficult to compare directly with our results, we would now like to report on our studies concerning firstly, the in vitro cytotoxity of the oxygen-bridged analog (SI^O-TT) [7] of Thio-TEPA, as compared to Thio-TEPA (TT), secondly, the comparison of the in vivo antitumor activity of SL-O-TT and SL-NH-TT with the parent compound TT, and thirdly, the qualitative ESR spectroscopy on tumor cells treated with the oxygenbridged spin labeled drug (Fig. 1) sented here is part of a long-range project in designing antitumor drugs containing nitroxyl labels to be studied for their antitumor potential and possible application in pharmacology and pharmacokinetics. The field of spin labeling has been expanding considerably in recent years [8] [9] [10] . In principle, the method consists of introducing a stable paramagnetic species, generally a nitroxyl moiety, into a biological or chemical system, and using ESR spectroscopy for the detection of these reporter groups. The evaluation of the ESR spectra yields information on the environment in which the spin labeled molecule is located. Nitroxyls are long-lived free radicals. The relatively low reactivity of nitroxyl radicals as compared to other long-lived radicals is attributed to the delocalized nature of the N-0 bond, >N-Ö<->N-Ö-, the steric hindrance caused by the bulky alkyl, usually methyl, groups in the a,a,a',a'-positions, and the inability of these a,a,a',a'-tetraalkyl substituted nitroxyl radicals to undergo a disproportionation reaction to nitrone and hydroxylamine derivatives, which is possible in the case of nitroxyl radicals containing a-hydrogens [10] . Unfortunately, there is also a drawback in using the nitroxyl radicals as reporter moieties, since they can readily undergo reductive reactions to the corresponding diamagnetic hydroxylamine derivatives [8] which cannot be detected by ESR. As a result, an oxidative treatment of reduced radicals is essential in order to apply the ESR techniques to such systems.
Materials and Methods
Pure Thio-TEPA (TT) was obtained from Lederle Laboratories (Pearl River, N. Y.) and used without further purification. Spin-labeled Thio-TEPA (SL-O-TT) was synthesized as previously described [7] . A colorimetric estimation of alkylating activity was performed by the method of Friedman and Boger [11] 
Results and Discussion
Analysis of the ESR spectrum of a freshly prepared solution of SL-O-TT gave a g value of g = 2.006 and a nitrogen coupling of aN=16.9 Gauss (Fig. 2 A) . At low modulation amplitudes, i.e., 0.05-0.1 Gauss, one can see hyperfine lines of approximately 0.5 Gauss, presumably due to interaction of the impaired electron with the methyl groups [14] . sonicated cells centrifuged at 700 X g in a table-top centrifuge for 20 min. The spectrum of the sediment, which is resuspended in a volume of saline equal to that of the supernatant, is identical to the spectrum of the drug in whole cells (Fig. 3A) , while the spectrum of the supernatant is that of a freely rotating drug. 
400X
On the basis of this series of experiments, it is concluded that SL-O-TT binds to the cells as expected, and that the drug is found both in the membranes and in the cytoplasm. It is conceivable that the drug may be embedded deeply in the membrane, since when the membranes are solubilized, the mobility of the spin label is increased (Fig. 3D) . Some basic questions remain to be answered, such as, whether the label remains attached to the parent compound and if so, whether the detection of the freely rotating label in the supernatant solution of sonicated cells reflects the presence of the free drug. In addition, it would be of interest to determine the origin of the signal in the sediment of sonicated cells (Fig. 30) . These questions can be answered, in part, by cell fractionation which could lead to a correlation of the presence of the label to the alkylating activity [11] . Subsequent research will deal with these problems. In addition, we will study the metabolic reduction rate(s) of the drug's label, using quantitative ESR techniques in conjunction with methods for the reoxidation of the reduced label. 75) . We chose to use TANOL to evaluate the possible contribution of the nitroxyl group to the drug's activity. Our results indicate that TANOL has no effect of its own. The doses which were used with this nitroxyl were, in general, higher than those used with SL-O-TT or SL-NH-TT, yet even at these higher doses, TANOL had no activity. At the highest dose used, (441 mg/kg), the animals convulse for about one hour and then return to normal. Nevertheless, this result does not necessarily mean that the nitroxyl moiety in the anticancer drug has no beneficial effect [6] .
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Conclusions
The results of our work using P 388 leukemia are in general agreement with those of Emanuel and coworkers [6] on the decreased toxicity of SL-NH-TT. However, no higher antitumor activity of SL-NH-TT as compared to TT is found against P 388 leukemia, unlike what was found by Emanuel and coworkers against other tumors [6] . On the basis of ESR experiments, it is evident that the label is rapidly reduced by cells in culture [18] [19] [20] , probably to the corresponding hydroxylamine derivative [18] . In order to use these compounds for pharmacokinetic purposes, it is essential to develop a technique for the reoxidation of the reduced label, ideally to >95% of its original concentration.
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